Jim Cramer sped through his take on caller favorite stocks, including embattled drug play Mylan.
The first ETF to invest in marijuana stocks has launched in Canada, but there's plenty of reason for investors to be high on skepticism.
Jim Cramer sped through his take on caller favorite stocks at lightning speed.
Jim Cramer outlined the stocks and events on his radar for next week.
Vivien Azer, Cowen & Co. analyst, explains why marijuana may be smoking the beer trade. The "Fast Money" traders weigh in.
Swearing in conference calls seems to be up in 2016. Here are some of the most profane moments.
CNBC's Jane Wells reports on where the legalization of recreational marijuana currently stands.
CNBC's Mike Santoli explores the market implications after the surprising presidential victory of Donald Trump.
SunTrust Robinson Humphrey said once recreational marijuana is legalized, Scotts Miracle-Gro sees an average jump of two times in its hydroponics business for that state.
JPMorgan forecasts $245 million of hydroponics-related sales in Scotts Miracle-Gro's fiscal 2017, up from $120 million in 2016.
Stocks closed lower, with information technology led decliners, as concerns over the presidential election lingered.
Stocks fell after the Federal Reserve kept interest rates unchanged, while investors eyed the presidential election.
U.S. equities fell as recent election news and a Fed meeting sent jitters through the market.
The Dow and S&P extended their slide to three months, while the Nasdaq snapped a three-month winning streak.
The presidential election's final days could present new headwinds for markets and overshadow the Fed meeting and the October jobs report.
A new marijuana referendum before California voters next month may lead the way for the rest of the country.
Jim Cramer goes through his lightning round of caller stocks, including what he sees ahead for Yum Brands after its split.
More states are considering measures to legalize pot, and marijuana shares are up more than 180 percent this year. Here's what you should know.
Is it ever right for corporate leaders to publically swear?
The “Fast Money Halftime Report” traders share their views on Scotts Miracle-Gro and Celgene. Dane Leone, BTIG analyst, weighs in on Celgene.